BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 1st Quarter - Report

INNOVATIVE BIO THERAPIES

via STRATEGIC FEDERAL AFFAIRS

1st Quarter (Jan 1 - Mar 31) · 2008Posted Apr 18, 2008Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: INNOVATIVE BIO THERAPIES
Description: Medical and Science Technology, Research and Development
Location: Michigan · United States of America

Registrant

Firm: STRATEGIC FEDERAL AFFAIRS
Description: Community College
Location: Brighton, Michigan, United States of America

Lobbying activities

1 issue

Defense
Bioartificial Kidney, Liver, Pancreas
LobbyistsJACK KIRKSEY · MARY JO KRIPOWICZ · COLLEEN POBUR
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

INNOVATIVE BIO THERAPIES — Lobbying — Receipts Report